Biomea Fusion, Inc.
General ticker "BMEA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $57.7M (TTM average)
Biomea Fusion, Inc. does not follow the US Stock Market performance with the rate: -7.8%.
Estimated limits based on current volatility of 2.4%: low 1.20$, high 1.26$
Factors to consider:
- Earnings expected soon, date: 2026-08-04 bmo
- Total employees count: 41 (-61.3%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Limited operating history, Operational and conduct risks, Need for additional capital, Clinical trial failure, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.83$, 2.97$]
- 2026-12-31 to 2027-12-31 estimated range: [0.90$, 3.08$]
Financial Metrics affecting the BMEA estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -106.21 <= 0.30
- Positive: Investing cash flow per share per price, % of 0 > -0.65
- Positive: 42.34 < Shareholder equity ratio, % of 50.45 <= 63.79
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term BMEA quotes
Long-term BMEA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $126.14MM | $144.07MM | $83.51MM |
| Operating Income | $-126.14MM | $-144.07MM | $-83.51MM |
| Non-Operating Income | $8.88MM | $5.64MM | $21.71MM |
| R&D Expense | $102.55MM | $118.08MM | $61.98MM |
| Income(Loss) | $-117.25MM | $-138.43MM | $-61.80MM |
| Net Income(Loss)* | $-117.25MM | $-138.43MM | $-61.80MM |
| Stockholders Equity | $169.24MM | $51.57MM | $29.55MM |
| Assets | $199.93MM | $79.94MM | $58.57MM |
| Operating Cash Flow | $-96.59MM | $-119.89MM | $-70.37MM |
| Capital expenditure | $3.37MM | $0.36MM | $0.00MM |
| Investing Cash Flow | $-2.22MM | $-0.36MM | $0.00MM |
| Financing Cash Flow | $163.80MM | $1.67MM | $67.90MM |
| Earnings Per Share** | $-3.44 | $-3.83 | $-1.18 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.